PubMed · 7462789
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
G Zechner. 1981. Histomorphological data on human auditory tube dysfunction.. https://doi.org/10.1017/s0022215100090666
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
HYPOTHESIS: Because many of the biologic phenomena in which mast cells are involved also are observed in human cholesteatoma pathology, the authors hypothesized that mast cells may play a role in this disease. The first test of this hypothesis is to determine whether there are an increased number of mast cells associated with cholesteatomas. BACKGROUND: The molecular and cellular defects that result in the pathologic features observed in acquired and congenital cholesteatomas are unknown. One common feature of cholesteatoma pathogenesis is the presence of bacteria and a numerous inflammatory cytokines expressed by host inflammatory cells. The interactions between inflammatory cells and cholesteatoma epithelium could result in the induction of other aberrant biologic features of cholesteatomas. Thus, it is critical to the understanding of the pathogenesis of cholesteatomas to define the specific role of each cell type involved in this disease. Connective tissue mast cells have a complex retinue of functions mediated via the secretion of a variety of cytokines and proteinases, and many of the biologic phenomena in which mast cells are involved also are observed in cholesteatoma pathology. METHODS: The authors evaluated by immunohistochemistry 36 cholesteatomas of all types (e.g., primary and secondary acquired, recurrent, and congenital) and 23 specimens of normal tissues (e.g., tympanic membrane, canal wall skin, and postauricular skin) for the expression of tryptase, a mast cell-specific protease. RESULTS: Cholesteatomas showed approximately threefold to sevenfold increase in the concentration of mast cells when compared with that of normal tissues. In addition, 19-34% of the mast cells were found within the suprabasal layers of the squamous epithelium of cholesteatoma subgroups, a phenomenon observed only in grossly inflamed tympanic membrane specimens, but not in other control tissues including minimally inflamed tympanic membranes. CONCLUSIONS: The authors conclude from these data that mast cells may represent a previously unrecognized host inflammatory cell, which plays an important role in the development of one or more traits of cholesteatoma pathology.
OBJECTIVE: This study aimed to document histologically the origin of congenital cholesteatoma in neonatal temporal bones. STUDY DESIGN: The study design was a systematic analysis of pediatric temporal bones. SETTING: The study was performed at the temporal bone laboratory, Tufts University School of Medicine and New England Medical Center, Boston, Massachusetts. RESULTS: We describe histologic findings of a congenital cholesteatoma and a squamous epithelial rest in two postpartum patients. In both patients, the masses were asymptomatic and occurred in the anterosuperior quadrant of the middle ear cleft. This is the first histologic documentation of postpartum congenital cholesteatoma. CONCLUSIONS: We believe that these cases represent the first clear histologic documentation of the origin of congenital cholesteatoma.
OBJECTIVE: This article provides an overview of the practice and utility of preoperative radiologic studies in chronic otitis media (COM). DATA SOURCES: A literature search of English language clinical and basic science publications was performed. Major otolaryngology texts were reviewed. Special attention was given to the clinical experience and recommendations of experienced otologic surgeons and radiologists regarding the use of radiologic studies in COM. CONCLUSIONS: There is no single accepted standard for the use of preoperative imaging in uncomplicated COM. Imaging studies, especially computed tomography (CT), can provide information regarding the nature and extent of disease, which may not be apparent on the basis of clinical findings alone. This information may impact the patient's operative management, especially in complex or revision cases. Each clinician must assess the benefits derived from these studies in his or her own practice.